Neuralstem, Inc. (NASDAQ:CUR) shares were up 8.9% on Friday . The company traded as high as $2.36 and last traded at $2.08. Approximately 2,552,100 shares traded hands during mid-day trading, an increase of 321% from the average daily volume of 606,638 shares. The stock had previously closed at $1.91.
Separately, S&P Equity Research reduced their price target on Neuralstem from $2.26 to $1.91 in a report on Thursday.
The stock has a market cap of $31.50, a price-to-earnings ratio of -1.25 and a beta of 1.60.
Neuralstem Company Profile
Neuralstem, Inc (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform.
Receive News & Ratings for Neuralstem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem and related companies with MarketBeat.com's FREE daily email newsletter.